SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-17-003646
Filing Date
2017-06-15
Accepted
2017-06-15 09:00:15
Documents
2
Period of Report
2017-06-12
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_061517.htm 8-K 17038
2 EXHIBIT 10.1 exh_101.htm EX-10.1 10400
  Complete submission text file 0001171843-17-003646.txt   28744
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21214 | Film No.: 17912487
SIC: 2834 Pharmaceutical Preparations